Unlocking the power of RNA in drug development
Hear insights from industry leaders on understanding, leveraging, and validating RNA in the drug development process.
Calvin Chao, MDSVP of Medical Affairs, Tempus
Brian Rini, MD, FASCOChief of Clinical Trials, Hematology & Oncology, Vanderbilt University Medical Center
Scott Haake, MD, PhDAssistant Professor of Medicine, Hematology & Oncology, Vanderbilt University Medical Center
Nilofer Azad, MDProfessor of Oncology, Co-Director, Developmental Therapeutics Program/Phase I Program Co-Leader, Cancer Genetics and Epigenetics, Sidney Kimmel Comprehensive Cancer Center Johns Hopkins University
Conference
